• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中间型地中海贫血患者的血清促红细胞生成素水平

Serum erythropoietin levels in thalassemia intermedia.

作者信息

Dore F, Bonfigli S, Gaviano E, Pardini S, Cianciulli P, Papa G, Longinotti M

机构信息

Institute of Hematology and Endocrinology, University of Sassari, Italy.

出版信息

Ann Hematol. 1993 Oct;67(4):183-6. doi: 10.1007/BF01695865.

DOI:10.1007/BF01695865
PMID:8218539
Abstract

Serum concentrations of erythropoietin (EPO) were determined by immunoassay in 45 patients with thalassemia intermedia (TI). The mean serum level of EPO was significantly higher in the thalassemic patients than in the controls, but transfused subjects had lower pretransfusional serum concentrations of EPO than untransfused ones. An inverse relationship between the serum values of EPO and total hemoglobin was observed only in the untransfused thalassemic patients. These data suggest that in TI, even a low transfusional regimen may cause a decrease in serum concentration of EPO, independent of the level of total Hb.

摘要

采用免疫分析法测定了45例中间型地中海贫血(TI)患者的血清促红细胞生成素(EPO)浓度。地中海贫血患者的血清EPO平均水平显著高于对照组,但接受输血的患者输血前血清EPO浓度低于未输血患者。仅在未输血的地中海贫血患者中观察到EPO血清值与总血红蛋白之间呈负相关。这些数据表明,在中间型地中海贫血中,即使是低输血方案也可能导致血清EPO浓度降低,而与总血红蛋白水平无关。

相似文献

1
Serum erythropoietin levels in thalassemia intermedia.中间型地中海贫血患者的血清促红细胞生成素水平
Ann Hematol. 1993 Oct;67(4):183-6. doi: 10.1007/BF01695865.
2
Serum erythropoietin levels in thalassemia major and intermedia.重型和中间型地中海贫血患者的血清促红细胞生成素水平
Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):786-8.
3
Erythropoietin activity in the serum of beta thalassemic patients.
Scand J Haematol. 1986 Sep;37(3):221-8. doi: 10.1111/j.1600-0609.1986.tb02301.x.
4
Serum erythropoietin levels in patients with beta thalassemia major and intermedia.重型和中间型β地中海贫血患者的血清促红细胞生成素水平。
Pediatr Hematol Oncol. 1997 Mar-Apr;14(2):161-7. doi: 10.3109/08880019709030902.
5
Blunted serum erythropoietin response to anemia in patients polytransfused for beta-thalassemia major.重度β地中海贫血多次输血患者血清促红细胞生成素对贫血的反应迟钝。
J Pediatr Hematol Oncol. 1998 Mar-Apr;20(2):140-4. doi: 10.1097/00043426-199803000-00010.
6
Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.高胎儿血红蛋白和低胎儿血红蛋白中间型β地中海贫血患者的血清促红细胞生成素与红细胞生成
Blood. 1994 Jan 15;83(2):561-5.
7
Serum erythropoietin in regularly transfused thalassemic patients.
Haematologia (Budap). 1991;24(3):129-34.
8
Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.地中海贫血患者的红细胞生成和铁代谢失衡。
Int J Med Sci. 2019 Jan 1;16(2):302-310. doi: 10.7150/ijms.27829. eCollection 2019.
9
Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia.血清免疫反应性促红细胞生成素水平:监测地中海贫血输血管理的新参数。
Nouv Rev Fr Hematol (1978). 1991;33(4):299-302.
10
Difference in pattern of erythropoietin response between beta-thalassemia/hemoglobin E children and adults.β地中海贫血/血红蛋白E患儿与成人促红细胞生成素反应模式的差异。
Southeast Asian J Trop Med Public Health. 1997;28 Suppl 3:134-7.

引用本文的文献

1
The transfusion management of beta thalassemia in the United States.美国β地中海贫血的输血管理
Transfusion. 2021 Oct;61(10):3027-3039. doi: 10.1111/trf.16640. Epub 2021 Aug 28.
2
Multimodality Imaging in Cardiac Amyloidosis.心脏淀粉样变性的多模态影像学。
Curr Cardiol Rep. 2021 Aug 19;23(10):134. doi: 10.1007/s11886-021-01564-6.
3
Erythropoiesis is not equally suppressed in transfused males and females with β-thalassemia major: are there clinical implications?重度β地中海贫血输血男性和女性的红细胞生成抑制程度不同:这有临床意义吗?

本文引用的文献

1
Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.异常血红蛋白的研究。I. 通过碱变性法在镰状细胞贫血和其他血液系统疾病中的显示
Blood. 1951 May;6(5):413-28.
2
Erythropoietin levels in heterozygous beta-thalassemia.
Acta Haematol. 1984;71(3):211-3. doi: 10.1159/000206587.
3
Sickle cell anemia patients have low erythropoietin levels for their degree of anemia.镰状细胞贫血患者的促红细胞生成素水平与其贫血程度相比偏低。
Haematologica. 2015 Aug;100(8):e292-4. doi: 10.3324/haematol.2014.118216. Epub 2015 Apr 24.
4
The antioxidant effect of erythropoietin on thalassemic blood cells.促红细胞生成素对地中海贫血血细胞的抗氧化作用。
Anemia. 2010;2010:978710. doi: 10.1155/2010/978710. Epub 2010 Dec 21.
5
Low doses of rHuEPO administered to adult patients with thalassemia intermedia.
Ann Hematol. 1994 Oct;69(4):211-2. doi: 10.1007/BF02215956.
Blood. 1986 Jan;67(1):46-9.
4
Erythropoietin activity in the serum of beta thalassemic patients.
Scand J Haematol. 1986 Sep;37(3):221-8. doi: 10.1111/j.1600-0609.1986.tb02301.x.
5
Erythropoietin levels in heterozygous alpha-thalassemia.
Acta Haematol. 1986;76(2-3):159-60. doi: 10.1159/000206042.
6
Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.
Blood. 1991 Aug 15;78(4):1145-7.
7
Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia.血清免疫反应性促红细胞生成素水平:监测地中海贫血输血管理的新参数。
Nouv Rev Fr Hematol (1978). 1991;33(4):299-302.